Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Guilin Sanjin Pharmaceutical claims novel saponins

Jan. 12, 2012

Chinese company patents new receptor tyrosine kinase inhibitors

Jan. 12, 2012

Japanese study supports in vivo antitumor activity of Golgi-disrupting agent

Jan. 12, 2012

Adherex continues enrollment in phase II eniluracil regimen study

Jan. 11, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

Phase II trial investigates effects of axitinib in metastatic melanoma

Jan. 11, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026